Back to Agenda
Q&A: Pre-Submitted Questions to the MHRA
Session Chair(s)
Louise Woodward, PHD
UK QPPV and Local Safety Responsible, Roche Products Ltd, United Kingdom
This session is dedicated to addressing participant questions about the pharmacovigilance aspects of the Windsor Framework. We have collected pre-submitted questions to ensure that we cover the most pressing topics. While our primary focus here is on pre-submitted questions, there will be an opportunity for live questions during the “Open Q&A from the Participants”.
Speaker(s)
Claire Longman, MSC
Expert Pharmacovigilance Inspector, Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom
Q&A: Pre-Submitted Questions to the MHRA
Sophie Radicke, MSC
Head of GPvP and Senior Pharmacovigilance Inspector, Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom
Q&A: Pre-Submitted Questions to the MHRA
Stephanie Millican, PHD, MSC
Deputy Director Benefit Risk Evaluation, Safety and Surveillance, MHRA, United Kingdom
Q&A: Pre-Submitted Questions to the MHRA
Have an account?